AGL Stock Recent News

Agilon Health (AGL 6.77%), a company that supports primary care physicians through a value-based care platform, reported earnings on August 4, 2025. Headline results were meaningfully weaker than expected.

LOS ANGELES--(BUSINESS WIRE)---- $AGL--AGL Investors Have Opportunity to Join agilon health, inc. Fraud Investigation with the Schall Law Firm.

The headline numbers for Agilon (AGL) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Agilon Health (AGL) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.07 per share a year ago.

Block & Leviton is investigating agilon health, Inc. for potential securities fraud. Investors who have lost money should contact the firm to learn more.

WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the second quarter ended June 30, 2025. As announced in a separate press release today, Steven Sell has stepped down as President, CEO and a Director of the Board, and the Company's co-founder and Board Chairman Ronald A. Williams has been appointed Executive Chairman while the Board conducts a search for a perman.

WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that Steven Sell has stepped down as President, CEO, and a Director of the Board. Ronald A. Williams, the Company's co-founder and Board Chairman since 2017, has been appointed Executive Chairman. Williams is an industry veteran with leadership experience at healthcare and technology companies including Aetna, where he was Chairman.

WEST CHESTER, Pa.--(BUSINESS WIRE)--Venerable Holdings, Inc. (“Venerable”), the leader in providing innovative risk transfer solutions to variable annuity issuers, is pleased to announce the commencement of new business variable annuity flow reinsurance with American General Life Insurance Company (“AGL”), an entity of Corebridge Financial, Inc. Additionally, Venerable has closed its reinsurance transaction with AGL, effective August 1, 2025. The flow reinsurance portion of the agreement involv.

The deal is Fluence's largest ever project transaction globally and one of the largest energy storage transactions by MWh in the Australian National Energy Market (NEM) to date, marking 5 GWh of projects by Fluence in Australia The deal is Fluence's largest ever project transaction globally and one of the largest energy storage transactions by MWh in the Australian National Energy Market (NEM) to date, marking 5 GWh of projects by Fluence in Australia

WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the second quarter 2025 after the market closes on Tuesday, August 5, 2025, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (404) 975-4839 for internationa.